• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    14.79 Dec 19, 4:00PM EST
    Add to Portfolio
    Analyst EstimatesGet Analyst Estimates for:
    Earnings EstCurrent Qtr.
    Dec 14
    Next Qtr.
    Mar 15
    Current Year
    Dec 14
    Next Year
    Dec 15
    Avg. Estimate-0.37-0.31-1.16-0.88
    No. of Analysts10.005.0010.0010.00
    Low Estimate-0.51-0.43-1.30-1.15
    High Estimate-0.25-0.23-1.04-0.43
    Year Ago EPS-0.21-0.15-0.58-1.16
    Revenue EstCurrent Qtr.
    Dec 14
    Next Qtr.
    Mar 15
    Current Year
    Dec 14
    Next Year
    Dec 15
    Avg. Estimate1.48M6.44M11.79M63.09M
    No. of Analysts1051010
    Low EstimateNaN3.21M10.00M34.90M
    High Estimate5.11M10.94M15.37M89.26M
    Year Ago SalesNaN10.00M7.00M11.79M
    Sales Growth (year/est)N/A-35.60%68.40%435.10%
    Earnings HistoryDec 13Mar 14Jun 14Sep 14
    EPS Est-0.16-0.08-0.25-0.27
    EPS Actual-0.21-0.15-0.24-0.38
    Difference-0.05-0.070.01-0.11
    Surprise %-31.20%-87.50%4.00%-40.70%
    EPS TrendsCurrent Qtr.
    Dec 14
    Next Qtr.
    Mar 15
    Current Year
    Dec 14
    Next Year
    Dec 15
    Current Estimate-0.37-0.31-1.16-0.88
    7 Days Ago-0.37-0.31-1.15-0.84
    30 Days Ago-0.37-0.31-1.16-0.77
    60 Days Ago-0.24-0.14-0.91-0.38
    90 Days Ago-0.23-0.10-0.89-0.36
    EPS RevisionsCurrent Qtr.
    Dec 14
    Next Qtr.
    Mar 15
    Current Year
    Dec 14
    Next Year
    Dec 15
    Up Last 7 Days0000
    Up Last 30 Days0000
    Down Last 30 Days0100
    Down Last 90 DaysN/AN/AN/AN/A
    Growth EstKERXIndustrySectorS&P 500
    Current Qtr.-76.20%N/A-68.20%17.60%
    Next Qtr.-106.70%N/A-39.70%17.20%
    This Year-100.00%N/A24.90%8.00%
    Next Year24.10%N/A0.90%9.10%
    Past 5 Years (per annum)0.00%N/AN/AN/A
    Next 5 Years (per annum)30.00%14.54%14.49%9.22%
    Price/Earnings (avg. for comparison categories)-12.75-11.712.8320.68
    PEG Ratio (avg. for comparison categories)-0.439.963.631.92
    Currency in USD.